South Dakota legislation · 100th Legislature (2025)
South Dakota HB1139: allow individualized investigative treatments for patients with life-threatening or debilitating diseases or conditions.
Status: Signed into law, March 31, 2025
What the bill says
An Act ENTITLED An Act to allow individualized investigative treatments for patients with life-threatening or debilitating diseases or conditions.
From the enrolled text:
An Act ENTITLED An Act to allow individualized investigative treatments for patients with life-threatening or debilitating diseases or conditions. Be it enacted by the Legislature of the State of South Dakota: Section 1. That § 34-51-1 be AMENDED: 34-51-1. Terms used in this chapter mean: (1) "Eligible facility," an institution operating under a federalwide assurance for the protection of human subjects, pursuant to 45 C.F.R. Part 46 (January 1, 2025); (2) "Eligible patient," an individual who has: (a) A disease or condition that is life-threatening or severely debilitating, as those terms are defined in 21 C.F.R § 312.81 (January 1, 2025), attested by the patient's treating physician; (b) Considered all other treatment options approved by the United States Food and Drug Administration; (c) Received a recommendation from the individual's treating physician for a general investigative treatment, or an individualized investigative treatment based on an analysis of the individual's genomic sequence, human chromosomes, deoxyribonucleic acid, ribonucleic acid, genes, gene products, or metabolites; (d) Given informed consent for the general or individualized investigative treatment; and (e) Documentation from the individual's treating physician that the individual meets the requirements of this chapter; (3) "General investigative treatment," any drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the …
Sponsors
- Bobbi Andera (R, HD-010) · primary sponsor
- Julie Auch (R, HD-018)
- Aaron Aylward (R, HD-006)
- Heather Baxter (R, HD-034)
- Eric Emery (D, HD-026)
- Leslie Heinemann (R, HD-025)
- Dylan Jordan (R, HD-004)
- Carl Perry (R, 03)
- Tony Randolph (R, HD-035)
- Christopher Reder (R, HD-001)
- Brandei Schaefbauer (R, HD-003)
Latest actions
- : Signed by the Governor
- : Delivered to the Governor
- : Signed by the President
- : Signed by the Speaker
- : Do Pass
- : Certified uncontested, placed on consent
- : Do Pass
- : Scheduled for hearing
- : First read in Senate and referred to Health and Human Services
- : Do Pass
Votes
- Do Pass (March 6, 2025): 34 yea, 0 nay, passed
- Do Pass (March 5, 2025): 7 yea, 0 nay, passed
- Do Pass (February 12, 2025): 68 yea, 0 nay, passed
- Do Pass (February 11, 2025): 13 yea, 0 nay, passed
Subjects: Health Care, Public Health and Safety, Insurance, Health Maintenance Organizations
Common questions
- What is HB1139?
- HB1139 is a bill in the South Dakota Legislature (100th Legislature (2025)): allow individualized investigative treatments for patients with life-threatening or debilitating diseases or conditions.
- What does HB1139 do?
- In its own words: An Act ENTITLED An Act to allow individualized investigative treatments for patients with life-threatening or debilitating diseases or conditions.
- What is the status of HB1139?
- Signed into law as of March 31, 2025. Latest action: Signed by the Governor (March 31, 2025).
- Who sponsored HB1139?
- Bobbi Andera (R, HD-010), with 10 co-sponsors.
- Where is the official record for HB1139?
- On the South Dakota Legislature website: https://sdlegislature.gov/Session/Bill/25942
Source: official South Dakota record. Tracked by Delilah, AI for legislation across all 50 states and Congress.